Lion Point Capital’s Fennec Pharmaceuticals FENC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.62M | Hold |
195,700
| – | – | 11.03% | 1 |
|
|
2025
Q1 | $1.19M | Hold |
195,700
| – | – | 7.6% | 4 |
|
|
2024
Q4 | $1.24M | Sell |
195,700
-19,300
| -9% | -$122K | 6.48% | 5 |
|
|
2024
Q3 | $1.08M | Buy |
215,000
+45,000
| +26% | +$225K | 2.39% | 9 |
|
|
2024
Q2 | $1.04M | Hold |
170,000
| – | – | 1.89% | 11 |
|
|
2024
Q1 | $1.89M | Buy |
170,000
+60,000
| +55% | +$667K | 1.06% | 7 |
|
|
2023
Q4 | $1.23M | Hold |
110,000
| – | – | 0.62% | 11 |
|
|
2023
Q3 | $826K | Hold |
110,000
| – | – | 0.37% | 14 |
|
|
2023
Q2 | $971K | Buy |
+110,000
| New | +$971K | 0.44% | 16 |
|